Serum amyloid A1–induced intrahepatic regulatory T-cell dysfunction drives autoimmune hepatitis progression Han Wang, Shuhui Wang, Yu Lei, Yu Chen, Zheng Huang, Shangshu Nie, Ping Han, Yujia Xia, Xinxia Feng, Jianyu Yu, Hao Li, Claire Chenwen Zhong, Wei Yan, Hai Huang, Dean Tian, Mei Liu Hepatology.2026; 83(5): 1049. CrossRef
Restoring immune tolerance in autoimmune hepatitis: therapeutic implications of the 2025 Nobel prize discoveries Krisztina Hagymási Structural Chemistry.2026; 37(2): 1041. CrossRef
Constructing a protein–protein interaction network for autoimmune liver diseases by integrating pQTL, rQTL, and mediation analyses Dianzhe Tian, Zuyi Yang, Lvyuxing Zhao, Haitao Zhao, Xinting Sang, Shunda Du, Yunping Luo, Lei Zhang, Yiyao Xu, Xin Lu Naunyn-Schmiedeberg's Archives of Pharmacology.2026; 399(8): 12461. CrossRef
Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study Jihye Lim, Ye-Jee Kim, Sehee Kim, Jonggi Choi JHEP Reports.2025; 7(2): 101251. CrossRef
Immune traits in combination with inflammatory proteins revealing the pathogenesis of autoimmune liver diseases: A Mendelian randomization study Feifan Wang, Lu Chen, Yu Tian Cytokine.2025; 185: 156815. CrossRef
Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study Sung Won Chung, Ye-Jee Kim, Jihye Lim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sehee Kim, Won-Mook Choi American Journal of Gastroenterology.2025; 120(10): 2302. CrossRef
A Closer Look into Autoimmune Liver Diseases Branka Filipovic, Marija Marjanovic-Haljilji, Dragana Blagojevic, Milica Dragovic, Emilija Krsmanovic, Ana Matovic, Natasa Panic, Stanimir Kiurski, Zagor Zagorac, Miljan Milanovic, Olivera Markovic, Aleksandra Djokovic, Tijana Glisic, Sanja Dragasevic, Du International Journal of Molecular Sciences.2025; 26(5): 1863. CrossRef
Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review Tatsuo Kanda, Reina Sasaki-Tanaka, Naruhiro Kimura, Hiroyuki Abe, Tomoaki Yoshida, Kazunao Hayashi, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Atsunori Tsuchiya, Kenya Kamimura, Shuji Terai International Journal of Molecular Sciences.2025; 26(5): 1883. CrossRef
Yinchenzhufu decoction ameliorates cholestatic liver injury through decreasing the formation of neutrophil extracellular traps in mice Qi Li, Qian Meng, Ningning Niu, Yiqian Li, Wenye Lu, Tianming Wang, Yuanyuan Li, Wanjun Ju, Yueming Ma, Jiasheng Wu Journal of Ethnopharmacology.2025; 347: 119720. CrossRef
Glycometabolic reprogramming of immune cells in autoimmune diseases Jin Lin, Fan Yang, Yanyi Zheng, Xianglin Wang, Xiaoli Fan, Li Yang Autoimmunity Reviews.2025; 24(10): 103876. CrossRef
PARP‑1 in liver diseases: Molecular mechanisms, therapeutic potential and emerging clinical applications (Review) Kaipeng Hu, Heng Tian, Shuxing Chen, Yuhan Liu, Ran Wei, Bangjie Chen, Yiwen Jia Molecular Medicine Reports.2025; 32(6): 1. CrossRef
A Preliminary Study on Clinical Characteristics of Patients With Autoimmune Liver Following Coronavirus Disease 2019 Chenchen Yang, Yu Hu, Juanjuan Fu, Wei Wang Journal of Tropical Medicine.2025;[Epub] CrossRef
Protective effects of Polygonum cuspidatum bioactive constituents against cholestatic liver injury: A mechanistic review Zengni Zhang, Xiao Yang, Yan Fu, Huilin Wei, Yajuan Chen, Anlin Dai, Xia Zhou, Jun Wan, Wenwen Chen Fitoterapia.2025; 187: 106938. CrossRef
Unlocking Mangiferin: A Therapeutic Candidate Revolutionizing Liver Disease Therapy Jihang Xie, Sijing Su, Jianfa Wu, Xing Yang, Qian Zhang, Xiaojiang Shen, Linlin Zhao, Ting Wang, Nana Feng, Jinsong Su, Yi Zhang Nutrients.2025; 17(21): 3401. CrossRef
Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center Seyed Erfan Mehdi Nejad, Mohammad Heiat, Mohammad Javanbakht, Seyed Moayed Alavian, Mohammad Ali Abyazi Haris BMC Gastroenterology.2024;[Epub] CrossRef
Artemisia capillaris Thunb. Polysaccharide alleviates cholestatic liver injury through gut microbiota modulation and Nrf2 signaling pathway activation in mice Jingyi Cai, Zhenyun Zhu, Yuanyuan Li, Qi Li, Tian Tian, Qian Meng, Tianming Wang, Yueming Ma, Jiasheng Wu Journal of Ethnopharmacology.2024; 327: 118009. CrossRef
JCAD, a new potential therapeutic target in cholestatic liver disease Byoung Kuk Jang Clinical and Molecular Hepatology.2024; 30(2): 166. CrossRef
Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis Atsumasa Komori Clinical and Molecular Hepatology.2024; 30(2): 157. CrossRef
Magnetic resonance imaging technique to quantify biomarkers for chronic liver diseases Yu. N. Savchenkov, G. E. Trufanov, V. A. Fokin, A. Yu. Efimtsev, S. E. Arakelov, I. Yu. Titova, A. R. Meltonyan Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2024; 14(1): 159. CrossRef
Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity Soomin Ahn, Sook-Hyang Jeong, Eun Ju Cho, Kyoungbun Lee, Gilhyang Kim, Haeryoung Kim Clinical and Molecular Hepatology.2023; 30(1): 37. CrossRef
Working Algorithms and Detection Methods of Autoantibodies in Autoimmune Liver Disease: A Nationwide Study Guillermo Muñoz-Sánchez, Albert Pérez-Isidro, Iñaki Ortiz de Landazuri, Antonio López-Gómez, Luz Yadira Bravo-Gallego, Milagros Garcia-Ormaechea, Maria Rosa Julià, Odette Viñas, Estíbaliz Ruiz-Ortiz Diagnostics.2022; 12(3): 697. CrossRef
First
Prev
